Down syndrome has existed for as long as humans have, and possibly longer. The oldest potential case comes from skeletal remains dating back over 72,000 years, and prehistoric populations in Europe show confirmed cases stretching back to at least 3600 BCE. What changed over time wasn’t the condition itself but our ability to recognize, name, and understand it.
Evidence From Prehistoric Remains
Down syndrome is caused by an extra copy of chromosome 21, a genetic event that can occur in any pregnancy regardless of era or population. Archaeological evidence confirms it happened regularly in the ancient world. A 2024 study published in Science Advances identified five cases of Down syndrome in individuals from prehistoric European populations dating between 400 BCE and 3629 BCE, detected through ancient DNA analysis. None of those five individuals survived beyond 16 months.
Even more striking, researchers have pointed to a skeleton known as LB1, now dated to over 72,000 years ago, that has been diagnosed with Down syndrome. That individual lived to an estimated age of 30 or older, suggesting some ancient communities provided enough care for people with the condition to reach adulthood.
Perhaps the most remarkable recent find involves a Neanderthal child. A fossil labeled CN-46700 shows inner ear abnormalities consistent with Down syndrome, and the individual lived to at least six years of age. If confirmed, this would mean Down syndrome predates our own species, appearing in Neanderthals as well. That finding makes sense genetically: the chromosomal mechanism behind Down syndrome is not unique to modern humans.
Down Syndrome in Renaissance Art
Long before any doctor described the condition, painters captured it. Medical researchers using a technique called iconodiagnosis (studying artworks through a medical lens) have identified multiple Renaissance paintings depicting children with features characteristic of Down syndrome: slanted eyes, a flattened nasal bridge, a protruding tongue, and curved pinky fingers.
The Italian painter Andrea Mantegna produced several works in the 1460s showing infants with these features. His “Madonna and Child” (1460) depicts a baby Jesus with oblique eyelid openings, a small nose, and an open mouth. At least three other Mantegna paintings show similar characteristics, and art historians and physicians have debated them for decades. An even earlier example appears in Filippo Lippi’s “Madonna of Humility” from 1430, where one of the angel faces surrounding the Virgin shows features suggestive of the condition.
Flemish painters depicted it too. Jacob Jordaens painted children with recognizable features in “Adoration of the Shepherds” (1617) and “The Satyr and the Peasants” (1635-1640). An anonymous Flemish work called “The Adoration of the Christ Child,” now in the Metropolitan Museum of Art in New York, shows both a child and a nearby shepherd with features consistent with Down syndrome. These paintings suggest that people with the condition were present and visible in everyday European life centuries before medicine had a name for it.
The First Medical Description in 1866
British physician John Langdon Down published the first clinical description in 1866, in an article titled “Ethnic Classifications of Idiots” in the London Hospital Reports. Down observed a distinct set of physical features among patients at the Royal Earlswood Asylum, noting that “a very large number of congenital idiots are typical Mongols.” He grouped patients by physical appearance and used racial categories that reflected the prejudices of Victorian science. The term “mongolism” became widely used in medicine for nearly a century afterward.
Down didn’t understand the genetic cause. He believed the condition represented a regression to what he considered a less developed racial type. But his detailed physical descriptions were accurate enough to establish Down syndrome as a recognizable diagnosis, separating it from the vague category of “idiocy” that had lumped together dozens of unrelated conditions.
The Genetic Cause Identified in 1959
The actual mechanism behind Down syndrome remained a mystery for 93 years after Down’s paper. In 1959, French geneticist Jérôme Lejeune and his colleagues Marthe Gautier and Raymond Turpin discovered that people with the condition have three copies of chromosome 21 instead of the usual two. This was one of the first times a human condition was linked to a specific chromosomal abnormality, and it transformed Down syndrome from a clinical observation into a genetically understood diagnosis. The formal term “trisomy 21” comes directly from this discovery.
How the Name Changed
The term “mongolism” persisted in medical literature well into the 1960s, but pressure to retire it came from multiple directions. In 1961, Lejeune and other international experts, along with John Langdon Down’s grandson Norman, petitioned the medical community to adopt a new name, arguing that “mongolism” was a misnomer with no scientific basis. In 1965, the World Health Organization officially dropped the term after a formal request from a delegation of the Mongolian People’s Republic, who objected to their national identity being used as a medical label. The condition was renamed Down syndrome, with “trisomy 21” as the scientific alternative.
Life Expectancy Then and Now
For most of human history, survival with Down syndrome was limited. The prehistoric cases identified through ancient DNA show most individuals dying in infancy. As recently as the early 1900s, children born with the condition in Western countries rarely survived past age 10, largely due to untreated heart defects and infections. About half of all babies born with Down syndrome have a congenital heart defect, which was essentially a death sentence before modern surgery.
Open heart surgery for congenital heart defects became widely available in the 1960s and early 1970s, but patients with Down syndrome were initially excluded from these procedures. Surgeons and institutions systematically refused to operate, reflecting societal attitudes that questioned whether children with intellectual disabilities deserved aggressive medical treatment. As surgical techniques improved and attitudes shifted, more infants with Down syndrome were referred for heart repair. Today, cardiac surgery is standard care, and the surgical mortality risk for children with Down syndrome is no higher than for the general pediatric population (except in cases involving the most complex single-ventricle heart defects).
That single change, along with better treatment of infections and other complications, dramatically extended life expectancy. By the 1980s, average life expectancy had risen into the mid-20s. Today, many people with Down syndrome live into their 60s. In the United States, roughly 5,700 babies are born with the condition each year, about 1 in every 640 births.
A Condition as Old as Chromosomes
Down syndrome is not a modern phenomenon or a product of any particular environment. It is a fundamental possibility built into how human chromosomes divide during reproduction. The same process that occasionally produces an extra copy of chromosome 21 has been occurring for tens of thousands of years, across every population and possibly across species. What has changed is not the condition itself but how long people who have it can expect to live, and how the world around them responds.